HyperPATH study cohort for all variables
Published: 21 November 2024| Version 1 | DOI: 10.17632/h588hz3pbt.1
Contributor:
Ezgi Caliskan GuzelceDescription
International Hypertensive Pathotype (HyperPATH) Consortium, HyperPATH study, has been an on-going, multi-site study, aimed at investigating the pathophysiologic and genotypic mechanisms involved in hypertension and cardiovascular diseases. Participants were studied at four collaborating centers: Brigham and Women’s Hospital (Boston, MA), University of Utah Medical Center (Salt Lake City, UT), Vanderbilt University Hospital (Nashville, TN), and Hôpital Européen Georges Pompidou (Paris, France).
Files
Institutions
Harvard Medical School, Harvard University
Categories
Cardiovascular Endocrinology, Sex Differentiation, Hypertension, Aldosterone